These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2398473)

  • 1. Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat.
    Gupta PK; Hung CT; Lam FC
    J Pharm Sci; 1990 Jul; 79(7):634-7. PubMed ID: 2398473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations.
    Cheung RY; Rauth AM; Yu Wu X
    Anticancer Drugs; 2005 Apr; 16(4):423-33. PubMed ID: 15746579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat.
    Gallo JM; Hung CT; Gupta PK; Perrier DG
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):305-26. PubMed ID: 2810070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of albumin and casein microspheres as a carrier for doxorubicin.
    Chen Y; Willmott N; Anderson J; Florence AT
    J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced effect of adriamycin on a rat liver adenocarcinoma after hepatic artery injection with degradable starch microspheres.
    el Hag IA; Teder H; Roos G; Christensson PI; Stenram U
    Sel Cancer Ther; 1990; 6(1):23-34. PubMed ID: 2343201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced toxicity of adriamycin by incorporation into ion exchange microspheres: a therapeutic study using a rat liver tumour model.
    Codde JP; Burton MA; Kelleher DK; Archer SG; Gray BN
    Anticancer Res; 1990; 10(6):1715-8. PubMed ID: 2285247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local arterial versus systemic adriamycin infusion therapy for sarcoma transplanted in the rat kidney.
    Tvete ST; Christensen J; Göthlin JH
    Anticancer Res; 1983; 3(5):353-60. PubMed ID: 6651237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.
    Jones C; Burton MA; Gray BN
    Br J Cancer; 1989 May; 59(5):743-5. PubMed ID: 2736208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

  • 16. Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat.
    Willmott N; Cummings J; Stuart JF; Florence AT
    Biopharm Drug Dispos; 1985; 6(1):91-104. PubMed ID: 3921079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.
    Olson HM; Capen CC
    Cancer Res; 1978 Jun; 38(6):1561-7. PubMed ID: 274173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.